RxDoctor Payments Data

Ann Jopling

Women's Health · Monroe, LANPI 1639132863

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Merck accounts for 64.5% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2021 at $12,795 and has fallen 94.9% since, to $650 in 2025. Among women's health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,355in general payments, 2019–2025

Across 75 payments — averaging $218.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$11K
  • Organon$2K
  • AstraZeneca$552
  • Abbott$355
  • Bayer$311
  • Novo Nordisk$309
  • plus $3K from 27 others

What the payments were for

  • Speaking & faculty fees$8,74053%
  • Travel & lodging$3,32120%
  • Food & beverage$4,29426%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,355 in reported general payments places this provider in the 95th percentile of 128 women's health providers in Louisiana.

See all women's health providers in Louisiana

Other women's health in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →